Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00084227 | Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America | PHASE2 | COMPLETED | 244 | — | — | Jul 1, 2004 | Jul 1, 2005 | May 11, 2011 | - | — |
| Name | Type | Description |
|---|---|---|
| Azithromycin/Chloroquine | DRUG | - |
| Atovaquone/Proguanil | DRUG | - |
Inclusion Criteria: * Written informed consent of the subject or a legally authorized representative * Females and males \>= 18 years of age with uncomplicated, symptomatic malaria as indicated by the presence of both of the following: a.) Blood smears positive for Plasmodium falciparum asexual par...